Cargando…

Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles

Herbal chemicals with a long history in medicine have attracted a lot of attention. Flavonolignans and flavonoids are considered as two classes of the above-mentioned compounds with different functional groups which exhibit several therapeutic capabilities such as antimicrobial, anti-inflammatory, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjbar, Shahla, Emamjomeh, Abbasali, Sharifi, Fatemeh, Zarepour, Atefeh, Aghaabbasi, Kian, Dehshahri, Ali, Sepahvand, Azadeh Mohammadi, Zarrabi, Ali, Beyzaei, Hamid, Zahedi, Mohammad Mehdi, Mohammadinejad, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383758/
https://www.ncbi.nlm.nih.gov/pubmed/37514130
http://dx.doi.org/10.3390/pharmaceutics15071944
_version_ 1785080989755637760
author Ranjbar, Shahla
Emamjomeh, Abbasali
Sharifi, Fatemeh
Zarepour, Atefeh
Aghaabbasi, Kian
Dehshahri, Ali
Sepahvand, Azadeh Mohammadi
Zarrabi, Ali
Beyzaei, Hamid
Zahedi, Mohammad Mehdi
Mohammadinejad, Reza
author_facet Ranjbar, Shahla
Emamjomeh, Abbasali
Sharifi, Fatemeh
Zarepour, Atefeh
Aghaabbasi, Kian
Dehshahri, Ali
Sepahvand, Azadeh Mohammadi
Zarrabi, Ali
Beyzaei, Hamid
Zahedi, Mohammad Mehdi
Mohammadinejad, Reza
author_sort Ranjbar, Shahla
collection PubMed
description Herbal chemicals with a long history in medicine have attracted a lot of attention. Flavonolignans and flavonoids are considered as two classes of the above-mentioned compounds with different functional groups which exhibit several therapeutic capabilities such as antimicrobial, anti-inflammatory, antioxidant, antidiabetic, and anticancer activities. Based on the studies, high hydrophobic properties of the aforementioned compounds limit their bioavailability inside the human body and restrict their wide application. Nanoscale formulations such as solid lipid nanoparticles, liposomes, and other types of lipid-based delivery systems have been introduced to overcome the above-mentioned challenges. This approach allows the aforementioned hydrophobic therapeutic compounds to be encapsulated between hydrophobic structures, resulting in improving their bioavailability. The above-mentioned enhanced delivery system improves delivery to the targeted sites and reduces the daily required dosage. Lowering the required daily dose improves the performance of the drug by diminishing its side effects on non-targeted tissues. The present study aims to highlight the recent improvements in implementing lipid-based nanocarriers to deliver flavonolignans and flavonoids.
format Online
Article
Text
id pubmed-10383758
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103837582023-07-30 Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles Ranjbar, Shahla Emamjomeh, Abbasali Sharifi, Fatemeh Zarepour, Atefeh Aghaabbasi, Kian Dehshahri, Ali Sepahvand, Azadeh Mohammadi Zarrabi, Ali Beyzaei, Hamid Zahedi, Mohammad Mehdi Mohammadinejad, Reza Pharmaceutics Review Herbal chemicals with a long history in medicine have attracted a lot of attention. Flavonolignans and flavonoids are considered as two classes of the above-mentioned compounds with different functional groups which exhibit several therapeutic capabilities such as antimicrobial, anti-inflammatory, antioxidant, antidiabetic, and anticancer activities. Based on the studies, high hydrophobic properties of the aforementioned compounds limit their bioavailability inside the human body and restrict their wide application. Nanoscale formulations such as solid lipid nanoparticles, liposomes, and other types of lipid-based delivery systems have been introduced to overcome the above-mentioned challenges. This approach allows the aforementioned hydrophobic therapeutic compounds to be encapsulated between hydrophobic structures, resulting in improving their bioavailability. The above-mentioned enhanced delivery system improves delivery to the targeted sites and reduces the daily required dosage. Lowering the required daily dose improves the performance of the drug by diminishing its side effects on non-targeted tissues. The present study aims to highlight the recent improvements in implementing lipid-based nanocarriers to deliver flavonolignans and flavonoids. MDPI 2023-07-14 /pmc/articles/PMC10383758/ /pubmed/37514130 http://dx.doi.org/10.3390/pharmaceutics15071944 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ranjbar, Shahla
Emamjomeh, Abbasali
Sharifi, Fatemeh
Zarepour, Atefeh
Aghaabbasi, Kian
Dehshahri, Ali
Sepahvand, Azadeh Mohammadi
Zarrabi, Ali
Beyzaei, Hamid
Zahedi, Mohammad Mehdi
Mohammadinejad, Reza
Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles
title Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles
title_full Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles
title_fullStr Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles
title_full_unstemmed Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles
title_short Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles
title_sort lipid-based delivery systems for flavonoids and flavonolignans: liposomes, nanoemulsions, and solid lipid nanoparticles
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383758/
https://www.ncbi.nlm.nih.gov/pubmed/37514130
http://dx.doi.org/10.3390/pharmaceutics15071944
work_keys_str_mv AT ranjbarshahla lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles
AT emamjomehabbasali lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles
AT sharififatemeh lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles
AT zarepouratefeh lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles
AT aghaabbasikian lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles
AT dehshahriali lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles
AT sepahvandazadehmohammadi lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles
AT zarrabiali lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles
AT beyzaeihamid lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles
AT zahedimohammadmehdi lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles
AT mohammadinejadreza lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles